Skip Navigation

Cardiovascular Research 2007 73(3):450-452; doi:10.1016/j.cardiores.2006.12.004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nitenberg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nitenberg, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

Macrovascular disease in type 2 diabetes: We do need animal models for in vivo studies

Alain Nitenberg*

AP-HP, Centre Hospitalier Universitaire Jean Verdier, Service de Physiologie et d'Explorations Fonctionnelles, Bondy, France, and Université Paris XIII, UFR Léonard de Vinci, Bobigny, France

* Service de Physiologie et d'Explorations Fonctionnelles, Hôpital Jean Verdier, Avenue du 14 Juillet, 93140 Bondy, France. Tel.: +33 1 48 02 65 50; fax: +33 1 48 02 65 67. Email address: alain.nitenberg@jvr.aphp.fr

Received 22 November 2006; accepted 5 December 2006

The first 10% of the full text of this article appears below.

See article by Bouvet et al. [6] (pages 504–511) in this issue.

Type 2 diabetes and its complications has become a major public health problem in Western countries. The number of diabetic patients in the world is estimated to be about 200 million, and prevalence of type 2 diabetes will increase not only in the West due to overweight and obesity epidemics, but also in emergent countries because of changes in eating habits.

In diabetic patients, atherosclerosis develops earlier than in other subjects and accounts for excessive morbidity and mortality [1]. Epidemiological studies have shown that cardiovascular diseases are the first cause of morbidity and mortality in patients with type 2 diabetes: coronary artery disease is . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?